Companies › LAB
STANDARD BIOTOOLS INC (LAB)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001162194 · EDGAR filings · Updated 2026-07-28
STANDARD BIOTOOLS INC (LAB) has reported institutional ownership of 76.2%, with 155 institutional managers holding positions valued at $273.4M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Filings this week (5)
- 2026-07-28 — 425 filed
- 2026-07-28 — 425 filed
- 2026-07-28 — Current report (8-K) filed
- 2026-07-27 — Insider transaction reported (Form 4)
- 2026-07-24 — Current report (8-K) filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-20 — 425 filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, STANDARD BIOTOOLS INC has 155 institutional holders and institutional ownership of 76.2%.
Insider activity
Insiders reported 62 transactions (24 buys, 9 sells) across 12 reporting insiders, with a net reported value of $16.2M.
Data flags from SEC filings
Related companies
FULGENT GENETICS INC (FLGT) · CERUS CORP (CERS) · CORMEDIX INC (CRMD) · SAB BIOTHERAPEUTICS INC (SABS) · REZOLUTE INC (RZLT) · ORTHOPEDIATRICS CORP (KIDS)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.